An Early Phase 1 interventional study of Collagen hydrolyzed peptides in Plantar Fascitis, sponsored by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-12-08.
Sponsored by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · Early Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Patients suffering from Plantar Fasciitis were randomized into three groups:
the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.
Patients suffering from Plantar Fasciitis were randomized into three groups:
the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.
Aim of the study was to consider any difference in the outcome of the three groups of patients. The NRS and the AFAS score were considered for the outcome measurement.
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari is the lead sponsor of 47 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Plantar fascitiis Aged between 18 and 80 years old
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
1\. Infiltration of collagen hydrolyzed peptides
Drug: Collagen hydrolyzed peptides
ESWT (Extracorporeal Shockwave Therapy)
Drug: Collagen hydrolyzed peptides
Combination of both treatments
Drug: Collagen hydrolyzed peptides
infiltration near the heal spur of 2ml of Arthrys
Also known as: ESWT
VAS (Visuoanalogic scale)
Visuoanalogic Scale during walking. Range 0 (No pain) -10 (maximum pain)
Time frame: Between recruitment and 30 days
AFAS (American Foot and Ankle Score) is the American Foot and Ankle Scale
It is a measurement of active ROM and deambulation of the patient. Range 0 (no function) -100 (perfect function)
Time frame: Between Recruitment and 15 days
AFAS is American Foot and Ankle Scale
It is a measurement of active ROM and deambulation of the patient (Range 0-100)
Time frame: Between Recruitment and 30 days
AFAS is American Foot and Ankle Scale
It is a measurement of active ROM and deambulation of the patient (Range 0-100)
Time frame: Between Recruitment and 60 days
Plan to share: No
Started Jul 2023 (actual). Primary completion is estimated for Dec 2025, 29 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Collagen
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari